Rockwell Medical acquires hemodialysis concentrates business from Evoqua Water; raises FY23 outlook

Rockwell Medical acquires hemodialysis concentrates business from Evoqua Water; raises FY23 outlook
Monday morning #earnings https://t.co/lObOE0dgsr $MNDY $WKHS $AZUL $CTLT $FREY $TSEM $TRVN $AMPS $NOVN $ZEV $HCDI $LLAP $SOHU $BITF $ISUN $CGAU $SNCE $VERO $ADN $RMTI $ALIM $GNS $CMRE $STRR $CGEN $TPG $DPSI $PDSB $GOGL $BCLI $SUNW $SGRP $LICY $LWAY $FATH $GRCL $NERV $PHGE $IMCC… https://t.co/T6t4wROLXV
25.7MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US7743743004
CUSIP
774374102
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
4.43
Book Value
0.91
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.15
Wall Street Target Price
3.00
EPS Estimate Current Year
-0.09
EPS Estimate Next Year
-0.01
EPS Estimate Current Quarter
-0.025
EPS Estimate Next Quarter
-0.025
Most Recent Quarter
-
Revenue TTM
67,680,000
Gross Profit TTM
11,550,000
EBITDA
-2,647,000
Profit Margin
-7.99%
Return On Assets TTM
-5.40%
Return On Equity TTM
-16.04%
Revenue Per Share TTM
1.814
Qtly Revenue Growth YOY
-8.30%
Diluted Eps TTM
-0.15
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
59
Price Sales TTM
0.3797
Price Book MRQ
0.7211
Enterprise Value Revenue
0
Enterprise Value EBITDA
30
9.36
0.48%238.05
0.00%13.60
0.00%89.55
0.00%44.11
-2.99%165.91
-2.41%29.43
-2.10%32.96
-1.88%15.86
-0.87%33.78
-0.41%